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CNK2 Couples NGF Signal Propagation to Multiple
Regulatory Cascades Driving Cell Differentiation
insulin-induced Ras-mediated activation of Raf, MEK,
and ERK in Drosophila S2 cells and that CNK is at least
partly responsible for recruiting Raf to the plasma mem-
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1Department of Cell Biology brane-enriched fraction of these cells [13]. The human
genome contains two predicted CNK orthologs, CNK1University of Texas Southwestern Medical Center
5323 Harry Hines Boulevard and CNK2/MAGUIN-1, which are 42% and 40% similar,
respectively, to Drosophila CNK. CNK1 has a broad ex-Dallas, Texas 75390-9039
2 Institut Curie pression profile, whereas CNK2 is restricted to neuronal
tissues. Similar to Drosophila CNK, mammalian CNK2Section de Recherche
26 Rue d’Ulm binds to the C terminus of Raf-1 and is targeted to the
plasma membrane by its PH domain [10, 14]. To reveal75248 Paris Cedex 05
France a potential contribution of CNK to Ras-Raf-MEK signal-
ing in mammalian cells, we examined the consequences
of inhibiting CNK2 expression in rat pheochromocytoma
PC12 cells. This cell line is a well characterized modelSummary
of ERK-dependent neuronal differentiation and is suited
for both biochemical and morphological analysis of MAPNeuronal precursor cells have the capacity to engage
kinase signaling [1]. We first tested the effect of CNK2the Raf-MEK-ERK signal module to drive either of two
inhibition on NGF-induced neurite outgrowth. We trans-distinctly different regulatory programs, proliferation
fected cells with siRNAs targeting CNK2 (CNK2-2313),and differentiation. This is, at least in part, a conse-
as well as with GFP to mark the transfectants, and thenquence of stimulus-specific shaping of the kinase cas-
we induced the cells to differentiate with NGF for 48 hr.cade response. For example, the mitogen EGF induces
As a positive control, we used siRNAs targeting thea transient ERK activation, whereas the neurotrophin
expression of the primary NGF receptor TrkA [15]. SiRNANGF induces prolonged ERK activation [1]. Here we
directed against human A-Raf, with no predicted targetdefine a novel component of the regulatory machinery
site in the rat genome, served as a negative control.contributing to the selective integration of MAP kinase
SiRNAs targeting TrkA and CNK2 significantly inhibitedsignaling with discrete biological responses. We show
NGF-induced PC12 cell differentiation (Figure 1A).that the scaffold/adaptor protein CNK2/MAGUIN-1 is
Quantitation of transfected cells showed that a TrkArequired for NGF- but not EGF-induced ERK activation.
siRNA completely blocked formation of NGF-dependentIn addition, CNK2 makes a separate, essential contri-
neurite-like extensions, whereas CNK2 siRNA resultedbution to the coupling of NGF signaling to membrane/
in approximately 70% suppression (Figure S1, in thecytoskeletal remodeling. We propose that CNK2 inte-
Supplemental Data available with this article online). Wegrates multiple regulatory pathways that must func-
observed similar results with a second independenttion in concert to drive an appropriate biological re-
siRNA sequence targeting CNK2 (CNK2-501); however,sponse to external stimuli.
we found that a third siRNA (CNK2-881) was ineffective
(data not shown). We assessed the relative activity and
Results and Discussion specificity of these siRNAs by targeting the expression
of Myc-tagged polypeptides corresponding to the
CNK2 Is Required for NGF-Induced PC12 aminocarboxyl terminal halves of CNK2. CNK2-2313 and
ell Differentiation CNK2-501 were both effective against their respective
The Raf-MEK-ERK kinase cascade is a core signal trans- targets. However, CNK2-881, which did not suppress
duction module implicated in the regulation of diverse NGF-induced neurite formation, did not have any activity
biological processes, ranging from cellular proliferation (Figure 1B). Because transfection efficiencies rarely ex-
and tumorigenesis to differentiation and cell specializa- ceeded 30%, we assayed the consequence of CNK2
tion [2, 3]. Little is currently understood about how the siRNA on endogenous CNK2 expression with rtPCR
cascade’s activity is appropriately integrated with multi- after sorting transfected (GFP-positive) cells (Figure S2).
ple regulatory pathways in order to contribute to dis-
crete biological responses. The generation of higher-
order molecular organization by scaffold proteins is one CNK2 Contributes to NGF- but Not EGF-Induced
mechanism that may help confer signaling specificity to ERK Activation
the Raf-MEK-ERK module [4–6]. Candidates include the To examine if suppression of neurite outgrowth by inhi-
putative scaffolding and linker proteins Kinase Suppres- bition of CNK2 expression correlates with inhibition of
sor of Ras (KSR) [7–9], Connector-enhancer of KSR NGF-mediated ERK activation, we measured the activa-
(CNK) [10], Suppressor of Ras-8 (Sur-8) [11], and MEK tion of endogenous ERK1/2 after ligand stimulation. We
Partner-1 (MP-1) [12]. examined ERK activation at the single cell level by using
Recently, we demonstrated that CNK is required for immunofluorescent labeling with a phospho-ERK-spe-
cific antibody. As opposed to control siRNA, SiRNAs
targeting either TrkA or CNK2 inhibited ERK activation in*Correspondence: michael.white@utsouthwestern.edu
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Figure 1. CNK2 Is Required for NGF-Induced Neurite Outgrowth in PC12 Cells
(A) Cells were transfected with GFP together with the indicated siRNAs. SiRNAs targeting human A-Raf (with no corresponding target in PC12
cells) were used as controls. Neurite formation was induced with 100 ng/ml NGF for 48 hr.
(B) PC12 cells were transfected with 0.8 g pCINeo-Myc-CNK2(amino acids 1–468) or pCINeo-Myc-CNK2(amino acids 568–1032), together
with 100 nM of the indicated siRNA and 0.1 g pCEP4-GFP, and immunostained to detect Myc expression. SiRNA names indicate base pair
positions in the CNK2 coding sequence.
response to NGF treatment. By contrast, EGF-mediated can discretely couple to distinct receptor tyrosine ki-
nases. They thereby reveal a novel control mechanismERK activation was unaffected (Figure 2). The distribu-
tion of phospho-ERK signal intensities was unaffected that may contribute to the specificity of signal propaga-
tion or signal integration.upon inhibition of CNK2 or TrkA in EGF-stimulated cells
but clearly collapsed to a basal (uninduced) state upon
inhibition of CNK2 or TrkA in NGF-stimulated cells (Fig- ERK-Independent Contribution of CNK2 to PC12
Cell Differentiationure S3). Western blot analysis of PC12 cell lysates
yielded similar results (Figure S4). Genetic and biochemical analysis has revealed Dro-
sophila CNK to be upstream of Raf and either down-The analysis described above indicates that CNK2 is
required for NGF-induced ERK activation and neurite stream of or parallel to Ras [10, 13]. Therefore, we acti-
vated the MAP kinase pathway at the level of Raf to testoutgrowth in PC12 cells. In contrast, EGF-induced ERK
activation is independent of CNK2 expression. These if it could bypass the requirement of CNK2 for neurite
outgrowth. PC12 cells were transfected with RafBXB, aobservations demonstrate that the MAP Kinase cascade
CNK2 Is Required for NGF Signaling
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Figure 2. CNK2 Is Required for NGF-Mediated ERK Activation
PC12 cells were transfected with the indicated siRNAs together with GFP, serum-starved for 18 hr, then stimulated for 5 min with EGF or
NGF (100 ng/ml each). After immunostaining with a phospho-ERK specific antibody, levels of activated ERK in the GFP-positive cells were
evaluated. Arrows indicate the transfected cells.
constitutively activated variant of Raf1 uncoupled from placenta cDNA library identified the tumor suppressor
DAL-1/band 4.1B [17] as a candidate CNK-interactingregulation by Ras, together with CNK2 siRNAs or con-
trol siRNAs. Unexpectedly, CNK2 siRNA suppressed protein. DAL-1 is a member of the band 4.1 family of
proteins that have been implicated in actin cytoskeletonRafBXB-induced neurites by approximately 65% in the
absence of inhibition of RafBXB-induced ERK activation regulation and plasma membrane organization [18, 19].
To verify this interaction in mammalian cells, we ex-(Figure 3A). This suggests that in addition to its contribu-
tion to NGF-stimulated ERK activation, CNK2 has an- pressed DAL-1 together with myc-tagged amino-termi-
nal and carboxy-terminal truncations of CNK2. As shownother distinct function, which is required in concert with
ERK activation for the successful formation of neurite in Figure 4A, DAL-1 can selectively associate with
CNK2(568–1032). In addition, endogenous CNK1 andlike projections.
The observation that transgenic expression of the DAL-1 coimmunoprecipitated in primary human foreskin
fibroblasts, thereby suggesting that this interaction isamino-terminal half of CNK in the fly eye enhances an
activated Ras-induced rough-eye phenotype in an ap- conserved between CNK isoforms (Figure S5).
Next, we examined the contribution of DAL-1/4.1B toparently MAP kinase-independent fashion suggests that
a Raf-MAP kinase-independent function exists for Dro- PC12 cell differentiation. Expression of 4.1B in PC12
cells has been previously reported [20] and was verifiedsophila CNK [16]. We found that, when expressed in
PC12 cells, the orthologous mammalian CNK2 molecule by PCR amplification from PC12 cDNA (data not shown).
As opposed to control siRNAs (Figure 4B), SiRNAs tar-(1–468) dominantly inhibited NGF-induced neurite out-
growth. However, NGF-induced ERK activation was not geting 4.1B, and verified by immunostaining, signifi-
cantly inhibited NGF-induced neurite outgrowth withoutaffected (Figure 3B). We then evaluated the impact of
CNK2(1–468) expression on RasV12-, RafBXB-, and inhibiting NGF-mediated ERK activation (Figure S6).
It remains to be determined if DAL-1/4.1B directlyMEKR4F-induced neurite formation. As shown in Figure
3C, CNK2(1–468) potently suppressed the morphologi- participates together with CNK2 to modulate neurito-
genesis. The molecular nature of the coupling of CNK2cal response of PC12 cells to all three activated compo-
nents of the Ras-MAP kinase pathway. CNK(1–468) did to morphological differentiation likely involves multiple
protein/protein interactions. Clearly, further work is war-not interfere with ERK activation by RasV12 (data not
shown). These results further indicate that CNK2 has a ranted to evaluate the relationship between CNK2 and
DAL-1/4.1B. However, our observations suggest that arole in PC12 cell differentiation that is distinct from its
contribution to NGF-induced ERK activation. CNK2/4.1B complex may be one component linking
NGF-signaling to the membrane cytoskeletal rearrange-
ments required for neurite extension.Band 4.1B/DAL-1 Interacts with CNK2 and Is
Required for Neurite Induction
To gain further understanding of CNK2 function, beyond CNK1 Modulates Actin Cytoskeleton Dynamics
As described above, CNK2 may integrate MAP kinaseMAP kinase signaling, we searched for novel molecular
partners of CNK2. A yeast two-hybrid screen of a human activation with the regulation of cytoskeleton/plasma
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Figure 3. CNK2 Is Required for Neurite Extension Independently of ERK Activation
(A) Left: PC12 cells were transfected with pSR-RafBXB together with the indicated siRNAs and immunostained with anti-Raf-1 antibody for
the detection of RafBXB expression. The number of RafBXB-positive cells with neurites longer than one cell body was determined as a
percentage of the total number of RafBXB-positive cells. The average standard deviation (SD) of the normalized results from three experiments
CNK2 Is Required for NGF Signaling
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Figure 4. DAL-1 Interacts with Mammalian CNK Isoforms and Is Required for Neurite Outgrowth
(A) HEK293 cells were transfected with the indicated constructs, lysed, and immunoprecipitated with anti-DAL-1 antibody.
(B) Left: PC12 cells were transfected with GFP together with the indicated siRNAs, and GFP-positive cells were evaluated for NGF-induced
neurite outgrowth. The average  SD of normalized results from three independent experiments is shown. Right: PC12 cells cotransfected
with siRNAs and GFP and immunostained to detect the expression of endogenous protein 4.1B.
(C) HeLa cells were transfected with siRNAs targeting RalA or CNK1, starved for 24 hr, and stimulated with 1 ng/ml EGF for the indicated
times. Lysates were analyzed on a Western blot with a phospho-ERK-specific antibody. RalA was used as a negative control, and c-Raf-1 is
shown as a loading control.
(D) HeLa cells were transfected with mismatch (MM) or CNK1 siRNAs and labeled with rhodamine-phalloidin for F-actin detection.
membrane dynamics to mediate PC12 cell differentia- sion did lead to a striking alteration in the cortical actin
cytoskeleton. This alteration correlated with a cobble-tion. CNK2 expression is restricted to neuronal cell types
[21], whereas the closely related family member CNK1 stone cell morphology that is similar to that adopted by
normal differentiated epithelial cells (Figure 4B). CNK1has a broader expression profile (NCBI database analy-
sis). As defined by rtPCR, HeLa cells do not express and CNK2 are 40% similar at the amino acid level and
may have conserved the capacity to participate in theCNK2 but do express CNK1 (data not shown; Figure
4C). We targeted the expression of CNK1 by using RNAi organization of cellular architecture.
In summary, the loss-of-function analysis presentedto assess its contribution to mitogen-dependent MAP
kinase signaling and regulation of actin-cytoskeletal here suggests that CNK2 is a key participant in NGF
receptor-specific signal propagation through both se-morphology. Similar to our observations of CNK2 func-
tion in PC12 cells, CNK1 did not appear to contribute lective coupling to ERK activation and integration with
membrane/cytoskeletal remodeling. CNK proteins di-to EGF-mediated activation of ERK in HeLa cells (Figure
4C). Nor could we reveal a contribution of CNK1 to the rectly interact with Raf kinases and may therefore func-
tion as multivalent scaffolds for the Raf-MAP kinaseactivation of MEK or ERK in response to PMA or LPA
(data not shown). However, inhibition of CNK1 expres- cascade by providing spatial and/or kinetic integration
is shown. Right: ERK activation in untransfected () or RafBXB-expressing () cells was quantitated on a single cell basis using a phospho-
ERK-specific antibody. The individual raw signal intensities are shown.
(B) Left: PC12 cells were transfected with pCEP4-GFP, pCIneo-Myc-CNK2(amino acids 1–468), or pCIneo-Myc-CNK2(amino acids 568–1032),
then treated with NGF for 48 hr or left untreated. CNK2 expression was detected by immunostaining with anti-Myc antibody. Right: PC12
cells transfected with pCIneo-Myc-CNK2(amino acids 1–468) or pCIneo-myc-CNK2(amino acids 568–1032) were serum-starved, stimulated
with 100 ng/ml NGF for 5 min, and immunostained with anti-phospho-ERK and anti-Myc antibodies. Arrows indicate transfected cells.
(C) PC12 cells were transfected with pDCR-RasV12, pSR-RafBXB, or pCMV5-MEK1R4F alone or in combination with pCIneo-myc-CNK2(amino
acids 1–468). After immunostaining to detect expression of the necessary constructs, cells were scored for the presence of neurites. The
average  SD of three independent experiments is shown.
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described above, but without NGF treatment, and immunostainedof the activity of this cascade with additional regulatory
with the appropriate antibodies.pathways required for an appropriate biological re-
sponse.
Immunocytochemistry
PC12 or HeLa cells were fixed in 3.7% formaldehyde for 1 hr, washed
Experimental Procedures
with PBS, and permeabilized for 1 hr in blocking buffer (0.25% Triton
X-100, 1% FCS, in PBS). Myc (A-14), v-H-Ras, Raf-1 (C-20), MEK-1
Cell Culture and Transfection
(H-8), and 4.1B antibodies and rhodamine-phalloidin were used at
PC12 cells were cultured in RPMI1640 medium supplemented with
1:80 dilution in blocking buffer. A 1:100 dilution of Phospho-ERK1/2
10% horse serum (heat inactivated for 25 min at 55C) and 5% FBS
antibody was used. A 1:300 dilution of goat anti-mouse or goat
and then transfected with Lipofectamine 2000 (Invitrogen, Carlsbad,
anti-rabbit fluorescent-conjugated antibodies was used for signal
CA) in LabTek 4-well chamber slides (Fisher Scientific, Pittsburgh,
detection(Jackson ImmunoResearch, West Grove, PA). Images were
PA). HEK293 cells and primary human foreskin fibroblasts were
collected with a Zeiss Axioplan 2 epifluorescence microscope and
cultured in DMEM without sodium pyruvate (Gibco, Carlsbad, CA)
Open Lab 2.2.5 imaging software.
with 10% FBS. HEK293 cells were transfected with Lipofectamine
2000. HeLa cells were cultured in DMEM supplemented with 10%
PC12 ERK Activation AssayFBS, and RNAi was performed with Oligofectamine (Invitrogen).
For ligand-induced ERK activation, cells were transfected with GFP
and siRNAs, and the medium was replaced with regular culture
siRNAs, Plasmids, and Antibodies
medium 24 hr posttransfection. After an additional 24 hr, cells were
The following siRNA sequences were used (numbers in CNK1 and
incubated in a low-serum medium for 18–24 hr before being stimu-
CNK2 oligo names refer to base pair positions in the respective
lated for 5 min with EGF (Calbiochem) or NGF (Alamone Labs). For
coding sequences). Rat: TrkA-FW, AUGUGGACAGAGGAGCAAATT;
RafBXB-induced ERK activation, 24 hr posttransfection cells were
TrkA-RV, UUUGCUCCUCUGUCCACAUTT; CNK2-2313-FW, UCGA
incubated in low-serum medium for 48 hr. After immunostaining
GACGCCACUGACAAGTT; CNK2-2313-RV, CUUGUCAGUGGCGUC
and image acquisition, phospho-ERK signal intensities in GFP- or
UCGATT; CNK2-551-FW, CAACAAUUGUGCAACAGGATT; CNK2-
RafBXB-expressing cells were analyzed with Open Lab software.
551-RV, UCCUGUUGCACAAUUGUUGTT; CNK2-881-FW, AAGC
GACCUCAGAGCAUGCTT; CNK2-881-RV, GCAUGCUCUGAGGUC
Immunoprecipitation and Western BlottingGCUUTT; 4.1B-FW, AGCAGAUUCGAAGUGGUGCTT; and 4.1B-RV,
For coimmunoprecipitation, HEK293 cells were lysed 48 hr afterGCACCACUUCGAAUCUGCUTT. Human: CNK1-805-FW, GAACAU
transfection in modified RIPA buffer (20 mM Tris, [pH 8.0], 137 mMGGUGAGGGAACUGTT; CNK1-805-RV, CAGUUCCCUCACCAUGU
NaCl, 10% glycerol, 1% Triton X-100, 0.5% sodium deoxycholate,UCTT; RalA-FW, CAGAGCUGAGCAGUGGAAUTT; RalA-RV, AUUCC
2 mM EDTA, 20 mM NaF, and protease inhibitors). Primary humanACUGCUCAGCUCUGTT; MM-FW, CACCUAAUCCGUGGUUCAATT;
foreskin fibroblasts were grown to full confluency in 10 cm cultureMM-RV, UUGAAGCACGGAUUAGGUGTT; and A-Raf-FW, GACGC
dishes (one 10 cm dish per IP) and lysed in modified RIPA buffer.GACAUGUCAACAUCTT; A-Raf-RV, GAUGUUGACAUGUCGCGUCTT.
Lysates were rotated for 20 min at 4C, cleared by centrifugation atpCEP4-GFP [22], pDCR-RasV12 [23], pSR-RafBXB [24], and
17,000  g for 15 min, and immunoprecipitated overnight with anti-pCMV5-MEK1R4F [25] are described elsewhere. pCIneo-Myc-
DAL-1 antibody. Immunoprecipitates were washed three times inCNK2(amino acids 1–468) and pCIneo-Myc-CNK2(amino acids 568–
lysis buffer and analyzed on a 10% agarose gel.1032) [21] were gifts from Yutaka Hata. pCDNA3-DAL-1(2A3) and
DAL-1 antibody [17] were gifts from Irene Newsham.
Supplemental DataAntibodies against c-Myc (A-14, 9E10), Raf-1 (C-20), MEK1 (H-8),
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